Dr. Nir Ayalon is an Interventional Cardiologist, with special interests in Heart Failure and Pulmonary Hypertension, as well as in new medical technologies and healthcare innovation. Dr. Ayalon had completed his medical school in Israel, had served as a physician in unique and classified units in the Israeli Defense Forces, and had completed his Internal Medicine Residency at Tel-Aviv Medical Center. Dr. Ayalon was trained at Boston University/Boston Medical Center, and completed a general cardiology fellowship, a heart failure and cardiomyopathy clinical and research fellowship, and an Interventional cardiology fellowship. Dr. Ayalon is now an assistant professor of Medicine at Boston University, and practices as an attending physician in Interventional cardiology, intensive Cardiac care inpatient service, as well as Heart Failure and Pulmonary Hypertension inpatient and ambulatory services.
- Attending Physician, Cardiovascular Medicine, Medicine, Boston Medical Center
- Published on 4/2/2019
Gopal DM, Ayalon N, Wang YC, Siwik D, Sverdlov A, Donohue C, Perez A, Downing J, Apovian C, Silva V, Panagia M, Kolachalama V, Ho JE, Liang CS, Gokce N, Colucci WS. Galectin-3 Is Associated With Stage B Metabolic Heart Disease and Pulmonary Hypertension in Young Obese Patients. J Am Heart Assoc. 2019 Apr 02; 8(7):e011100. PMID: 30929550.
- Published on 7/24/2017
Ho JE, Rahban Y, Sandhu H, Hiremath PG, Ayalon N, Qin F, Perez AJ, Downing J, Gopal DM, Cheng S, Colucci WS. Preclinical Alterations in Myocardial Microstructure in People with Metabolic Syndrome. Obesity (Silver Spring). 2017 Sep; 25(9):1516-1522. PMID: 28737258.
- Published on 2/8/2016
Ayalon N, Jacobs AK. Incomplete Revascularization in Patients Treated With Percutaneous Coronary Intervention: When Enough Is Enough. JACC Cardiovasc Interv. 2016 Feb 8; 9(3):216-8. PMID: 26847113.
- Published on 7/14/2015
Wang YC, Liang CS, Gopal DM, Ayalon N, Donohue C, Santhanakrishnan R, Sandhu H, Perez AJ, Downing J, Gokce N, Colucci WS, Ho JE. Preclinical Systolic and Diastolic Dysfunctions in Metabolically Healthy and Unhealthy Obese Individuals. Circ Heart Fail. 2015 Sep; 8(5):897-904. PMID: 26175540.
- Published on 3/10/2015
Gopal DM, Santhanakrishnan R, Wang YC, Ayalon N, Donohue C, Rahban Y, Perez AJ, Downing J, Liang CS, Gokce N, Colucci WS, Ho JE. Impaired right ventricular hemodynamics indicate preclinical pulmonary hypertension in patients with metabolic syndrome. J Am Heart Assoc. 2015 Mar; 4(3):e001597. PMID: 25758604.
- Published on 7/1/2014
Ayalon N, Gopal DM, Mooney DM, Simonetti JS, Grossman JR, Dwivedi A, Donohue C, Perez AJ, Downing J, Gokce N, Miller EJ, Liang CS, Apovian CM, Colucci WS, Ho JE. Preclinical left ventricular diastolic dysfunction in metabolic syndrome. Am J Cardiol. 2014 Sep 15; 114(6):838-42. PMID: 25084691.
- Published on 4/28/2013
Ayalon N, Flore LA, Christensen TG, Sam F. Mitochondrial encoded NADH dehydrogenase 5 (MT-ND5) gene point mutation presents as late onset cardiomyopathy. Int J Cardiol. 2013 Sep 1; 167(5):e143-5. PMID: 23628297.
- Published on 10/25/2012
Gopal DM, Kommineni M, Ayalon N, Koelbl C, Ayalon R, Biolo A, Dember LM, Downing J, Siwik DA, Liang CS, Colucci WS. Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure. J Am Heart Assoc. 2012 Oct; 1(5):e000760. PMID: 23316284.
- Published on 4/7/2011
Tirosh A, Shai I, Afek A, Dubnov-Raz G, Ayalon N, Gordon B, Derazne E, Tzur D, Shamis A, Vinker S, Rudich A. Adolescent BMI trajectory and risk of diabetes versus coronary disease. N Engl J Med. 2011 Apr 07; 364(14):1315-25. PMID: 21470009.
- Published on 6/14/2010
Tirosh A, Afek A, Rudich A, Percik R, Gordon B, Ayalon N, Derazne E, Tzur D, Gershnabel D, Grossman E, Karasik A, Shamiss A, Shai I. Progression of normotensive adolescents to hypertensive adults: a study of 26,980 teenagers. Hypertension. 2010 Aug; 56(2):203-9. PMID: 20547973.
View 1 more publications: View full profile at BUMC